- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pila Pharma AB (PILA)
The Pila Pharma AB share price today is 1.88, view ST PILA stock exchange data. Track the latest Pila Pharma AB share price with real-time updates on PILA stock performance including market cap, day range, 52-week range and dividend yield. Access PILA charts, earnings dates and analyst estimates to support your investment decisions.
Stockholm
Currency in SEK
1.88
+0.18(+10.59%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.70
1.97
52 wk Range
1.02
2.60
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.701.97
52 wk Range
1.022.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PILA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Pila Pharma AB Earnings Call Summary for Q2/2025
- Raised 30M SEK through oversubscribed rights issue; stock down 59.18% YoY
- Developing oral TRPAV1 inhibitor for obesity; preclinical studies in autumn
- Pre-revenue status maintained; consistent burn rate reported
- CEO emphasizes enduring obesity market; cautious on promises
- Risks include market competition, trial outcomes, and regulatory hurdles
Last Updated: 27-08-2025, 05:26 pm
Read Full TranscriptEarnings
Latest Release
10-02-2026
EPS / Forecast
-0.41 / --
Revenue / Forecast
276K / --
Compare PILA to Peers and Sector
Metrics to compare | PILA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPILAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.1x | 0.0x | −0.4x | |
PEG Ratio | 0.45 | 0.00 | 0.00 | |
Price/Book | 5.9x | 0.0x | 2.6x | |
Price / LTM Sales | 76.2x | 0.0x | 3.1x | |
Upside (Analyst Target) | 33.0% | 0.0% | 48.6% | |
Fair Value Upside | Unlock | 0.0% | 5.8% | Unlock |
Pila Pharma AB (publ) operates as a clinical stage biotech company in Sweden. The company develops XEN-D0501, a TRPV1 antagonist in Phase 2a trial for obesity, diabetes, and heart failure; Phase 1 trial for erythromelalgia, inflammation pain, and rare diseases; and preclinical trial for abdominal aorta aneurism and cardiovascular diseases. Pila Pharma AB (publ) was incorporated in 2014 and is headquartered in Malmö, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Pila Pharma AB (PILA) Share Price Today?
The Pila Pharma AB share price today is 1.88.
What is the current Pila Pharma AB (PILA) share price and day range?
As of 24-08-2026, the Pila Pharma AB share price is 1.88, with a previous close of 1.70. The share price has ranged from 1.70 to 1.97 today, while the 52-week range spans from 1.02 to 2.60.
What Is the Pila Pharma AB Market Cap?
As of today, Pila Pharma AB market cap is 85.88M.
What Is the Pila Pharma AB (PILA) Share Price Target?
The average 12-month share price target for Pila Pharma AB is 2.50, with a high estimate of 2.5 and a low estimate of 2.5. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +32.98% Upside potential.
What Is Pila Pharma AB's Earnings Per Share (TTM)?
The Pila Pharma AB EPS (TTM) is -0.49.
From a Technical Analysis Perspective, Is PILA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Pila Pharma AB Trade On?
Pila Pharma AB is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Pila Pharma AB?
The stock symbol for Pila Pharma AB is "PILA."
How Many Times Has Pila Pharma AB Stock Split?
Pila Pharma AB has split 0 times.
How Many Employees Does Pila Pharma AB Have?
Pila Pharma AB has 1 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.